Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
(
1 selected
)
Type
Guidance (756)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (27)
Interventional procedures guidance (598)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (756)
Apply filters
Showing 701 to 725 of 756
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma
TA169
25 March 2009
25 March 2009
Amantadine, oseltamivir and zanamivir for the treatment of influenza
TA168
25 February 2009
25 February 2009
Machine perfusion systems and cold static storage of kidneys from deceased donors
TA165
28 January 2009
28 January 2009
Infliximab for acute exacerbations of ulcerative colitis
TA163
17 December 2008
17 December 2008
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin
TA159
22 October 2008
22 October 2008
Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults
TA157
24 September 2008
24 September 2008
Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza
TA158
24 September 2008
24 September 2008
Routine antenatal anti-D prophylaxis for women who are rhesus D negative
TA156
27 August 2008
27 August 2008
Entecavir for the treatment of chronic hepatitis B
TA153
27 August 2008
27 August 2008
Telbivudine for the treatment of chronic hepatitis B
TA154
27 August 2008
27 August 2008
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus
TA151
23 July 2008
23 July 2008
Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal)
TA148
25 June 2008
25 June 2008
Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal)
TA149
25 June 2008
25 June 2008
Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck
TA145
25 June 2008
25 June 2008
Adalimumab for the treatment of adults with psoriasis
TA146
25 June 2008
25 June 2008
Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over
TA138
26 March 2008
26 March 2008
Structural neuroimaging in first-episode psychosis
TA136
27 February 2008
27 February 2008
Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
TA137
27 February 2008
27 February 2008
Infliximab for the treatment of adults with psoriasis
TA134
23 January 2008
23 January 2008
Pemetrexed for the treatment of malignant pleural mesothelioma
TA135
23 January 2008
23 January 2008
Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years
TA131
28 November 2007
28 November 2007
Bortezomib monotherapy for relapsed multiple myeloma
TA129
23 October 2007
23 October 2007
Stapled haemorrhoidopexy for the treatment of haemorrhoids
TA128
26 September 2007
26 September 2007
Pemetrexed for the treatment of non-small-cell lung cancer
TA124
22 August 2007
22 August 2007
Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis
TA127
22 August 2007
22 August 2007
Previous page
1
…
27
28
Current page
29
30
31
Page
29
of
31
Next page
Results per page
10
25
50
All
Back to top